Showing results (211-220 of 243) with videos related to
Sort By:
Pageof 25
Aging Cell|September 30, 2021
Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female miceMaaike Schilperoort, Jan Kroon, Sander Kooijman, et al.Journal of Neuroendocrinology|March 8, 2025
Selective changes in vasopressin neurons and astrocytes in the suprachiasmatic nucleus of Prader-Willi syndrome subjectsFelipe Correa-da-Silva, Jari B Berkhout, Pim Schouten, et al.British Journal of Pharmacology|March 19, 2016
Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammationJosé K van den Heuvel, Mariëtte R Boon, Ingmar van Hengel, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 6, 2015
Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's DiseaseSteven J A van der Werff, J Nienke Pannekoek, Cornelie D Andela, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 2015
Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)Joanne M de Laat, Olaf M Dekkers, Carolina R C Pieterman, et al.International Journal of Environmental Research and Public Health|December 1, 2020
The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical OutcomesSalma R Ali, Jillian Bryce, Li En Tan, et al.European Journal of Endocrinology|December 26, 2023
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgeryKristina Isand, Richard Feelders, Thierry Brue, et al.The American Journal of Cardiology|October 6, 2009
Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery diseaseRoxana Djaberi, Joanne D Schuijf, Eelco J de Koning, et al.European Journal of Endocrinology|February 20, 2025
Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statementKristina Isand, Hiroshi Arima, Jerome Bertherat, et al.The Lancet Regional Health. Europe|July 29, 2024
Lanreotide versus placebo for tumour reduction in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessmentTessel M Boertien, Madeleine L Drent, Jan Booij, et al.Pageof 25